Phytotherapy in the treatment of benign prostatic hyperplasia
- 1 January 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 12 (1) , 15-18
- https://doi.org/10.1097/00042307-200201000-00004
Abstract
There are numerous plant extracts that have been used for the treatment of benign prostatic hyperplasia and lower urinary tract symptoms. While some extracts show promise, their efficacy has not been adequately proven in long-term, double-blind placebo-controlled trials monitored by an outside agency.Keywords
This publication has 12 references indexed in Scilit:
- Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgensUrology, 2001
- Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon®) in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 2000
- SAW PALMETTO FOR THE TREATMENT OF MEN WITH LOWER URINARY TRACT SYMPTOMSJournal of Urology, 2000
- Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasiaUrology, 2000
- Effect of Beta–Sitosterol on Transforming Growth Factor–Beta–1 Expression and Translocation Protein Kinase C Alpha in Human Prostate Stromal Cells in vitroEuropean Urology, 2000
- Phytotherapy in the treatment of benign prostatic hyperplasia: an updateUrology, 1999
- Saw Palmetto (Serenoa repens) in Men with Lower Urinary Tract Symptoms: Effects on Urodynamic Parameters and Voiding SymptomsUrology, 1998
- Transforming Growth Factor- 1 Inhibits Membrane Association of Protein Kinase C in a Human Prostate Cancer Cell Line, PC3Endocrinology, 1997
- Stromal cells of the human prostate: Initial isolation and characterizationThe Prostate, 1996
- Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasiaThe Lancet, 1995